Matches in Wikidata for { <http://www.wikidata.org/entity/Q37718297> ?p ?o ?g. }
- Q37718297 description "article científic" @default.
- Q37718297 description "article scientifique" @default.
- Q37718297 description "articolo scientifico" @default.
- Q37718297 description "artigo científico" @default.
- Q37718297 description "artículu científicu espublizáu en 2014" @default.
- Q37718297 description "bilimsel makale" @default.
- Q37718297 description "scientific article published on 15 January 2014" @default.
- Q37718297 description "vedecký článok" @default.
- Q37718297 description "vetenskaplig artikel" @default.
- Q37718297 description "videnskabelig artikel" @default.
- Q37718297 description "vědecký článek" @default.
- Q37718297 description "wetenschappelijk artikel" @default.
- Q37718297 description "wissenschaftlicher Artikel" @default.
- Q37718297 description "наукова стаття, опублікована в січні 2014" @default.
- Q37718297 description "научни чланак" @default.
- Q37718297 description "مقالة علمية نشرت في 15 يناير 2014" @default.
- Q37718297 name "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 name "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 name "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 type Item @default.
- Q37718297 label "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 label "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 label "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 prefLabel "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 prefLabel "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 prefLabel "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 P1433 Q37718297-2D3D49F0-9C68-4646-A48F-27292ED5AEBF @default.
- Q37718297 P1476 Q37718297-DC07A762-7BB9-4DE4-BBB4-0FD878A6DB25 @default.
- Q37718297 P2093 Q37718297-1FA7810C-7B82-4BA7-A1F0-489C7EA696E1 @default.
- Q37718297 P2093 Q37718297-84E3353B-648C-403D-84A5-3EE4DBC7EE23 @default.
- Q37718297 P2093 Q37718297-88462051-B70D-4605-B30F-97EFD5BC2DA0 @default.
- Q37718297 P2093 Q37718297-9EC68299-9578-434D-82BD-5CDD93504464 @default.
- Q37718297 P2093 Q37718297-C72AFAE6-E92A-4AD1-9FEC-F1AAD5975F7E @default.
- Q37718297 P2860 Q37718297-04533D14-E537-43D2-B795-053C922FDE2B @default.
- Q37718297 P2860 Q37718297-0F5AEB10-1129-4149-B676-656F2AC1DD1F @default.
- Q37718297 P2860 Q37718297-198A54F4-04B3-45BA-87C3-BC71FC386DD4 @default.
- Q37718297 P2860 Q37718297-27D2ACFF-E866-4F46-9822-D43026B8CCDD @default.
- Q37718297 P2860 Q37718297-2ABE3243-2976-4464-A5F5-60A79656FF49 @default.
- Q37718297 P2860 Q37718297-2D335F57-3F05-4E9F-B348-783FFEDE4402 @default.
- Q37718297 P2860 Q37718297-33B81962-F4C7-420A-83A1-A056F8B132B3 @default.
- Q37718297 P2860 Q37718297-4F2FCAEE-AB45-4B89-8AF6-B3027B79232F @default.
- Q37718297 P2860 Q37718297-51A5FC9F-1E38-45C0-90F1-744261158D22 @default.
- Q37718297 P2860 Q37718297-5CDEA087-4988-4798-8BA8-F464E5BFB3DB @default.
- Q37718297 P2860 Q37718297-64F41F2F-6F68-4E2E-9446-EFF0E6B10568 @default.
- Q37718297 P2860 Q37718297-6E9B88F6-874E-4E55-AF9C-61F756B85D53 @default.
- Q37718297 P2860 Q37718297-7178EE29-B9CE-4BF5-A174-FE90EBC4629B @default.
- Q37718297 P2860 Q37718297-7BE124DC-2186-4A63-B601-455C4C459FDD @default.
- Q37718297 P2860 Q37718297-7DE363B8-C205-403A-A478-9689CCFC3FBA @default.
- Q37718297 P2860 Q37718297-7EAEE59C-0C5D-4DFA-BCEC-903BB60FCBA6 @default.
- Q37718297 P2860 Q37718297-87A7F47B-FCE2-41FB-9C4D-9BB6D987F474 @default.
- Q37718297 P2860 Q37718297-892E0A22-B6C5-4E3E-8E05-8DA3A73DA69F @default.
- Q37718297 P2860 Q37718297-9A3CCAE1-D65E-4579-9261-4C2D2AAC306B @default.
- Q37718297 P2860 Q37718297-9CDE9A80-C7D0-4EFF-A834-BB0A480D4434 @default.
- Q37718297 P2860 Q37718297-A3023620-9988-4E3C-B110-DCCCF3DCEB8C @default.
- Q37718297 P2860 Q37718297-A6A8CDE1-C3EC-48AF-948A-3DC7991079A0 @default.
- Q37718297 P2860 Q37718297-AB8B5A24-264C-452E-A099-F56555301B35 @default.
- Q37718297 P2860 Q37718297-B966A0FB-5CF5-463F-AE5E-25748AEB40D5 @default.
- Q37718297 P2860 Q37718297-B991436F-ED64-416A-85BF-C9A9FB0DB138 @default.
- Q37718297 P2860 Q37718297-BADB3705-0B0D-4E29-A952-2364F5DBBC30 @default.
- Q37718297 P2860 Q37718297-C3C2EA55-D7F9-4FA3-AD91-39D4AE007E89 @default.
- Q37718297 P2860 Q37718297-D9C08630-84EA-4F9D-97E8-56D2BC3EC0BD @default.
- Q37718297 P2860 Q37718297-E5C45EAD-9241-4986-BD03-3BF655647A10 @default.
- Q37718297 P2860 Q37718297-F85129D2-204D-4354-8E91-9CB57602FA77 @default.
- Q37718297 P304 Q37718297-8A9FA56B-98C8-4872-99F9-FC13C031295B @default.
- Q37718297 P31 Q37718297-7B3B0E87-CF79-4684-880C-05F8C773BCAF @default.
- Q37718297 P356 Q37718297-07BFF687-2036-46BF-9977-85D88D09B5A6 @default.
- Q37718297 P407 Q37718297-36F72E27-E9C9-44C3-80FA-AD9C35883349 @default.
- Q37718297 P433 Q37718297-2AFDBE3D-79D5-4E80-AF0E-82BFB1D5A915 @default.
- Q37718297 P478 Q37718297-0CE6D7E9-749A-4891-A362-5FD9E9FAA16F @default.
- Q37718297 P50 Q37718297-0D79DFFE-51A9-427E-8A64-4364D4D46615 @default.
- Q37718297 P50 Q37718297-2F609DBE-8ACD-401D-9086-E2B943F717A7 @default.
- Q37718297 P50 Q37718297-399C85BD-380B-4281-AEF2-A1C4B3DA6B83 @default.
- Q37718297 P50 Q37718297-4781EACE-C725-4243-84A1-B696A1C839EF @default.
- Q37718297 P50 Q37718297-81C40673-455A-4C9A-B96D-CEDF4F487D84 @default.
- Q37718297 P50 Q37718297-A26BD449-A219-48BC-8487-343B351696AA @default.
- Q37718297 P50 Q37718297-A7181C79-5CB8-444A-B164-DEF80718AD7B @default.
- Q37718297 P577 Q37718297-867A8754-B9F9-4967-82D8-8A12FF3AC5CD @default.
- Q37718297 P698 Q37718297-6BAEDE58-593C-467F-94A3-895979D491CF @default.
- Q37718297 P921 Q37718297-01349192-02BA-4F19-B28F-D39484599728 @default.
- Q37718297 P921 Q37718297-651F301E-9DAF-4683-962D-D7F81F7136C5 @default.
- Q37718297 P921 Q37718297-9E9D2B42-10EB-45E6-85A8-6462713AA645 @default.
- Q37718297 P921 Q37718297-E8622747-74B3-4979-B11E-1514B49CF120 @default.
- Q37718297 P932 Q37718297-B3F50506-5577-44D6-A015-FDE5664B671E @default.
- Q37718297 P356 BJH.12736 @default.
- Q37718297 P698 24428673 @default.
- Q37718297 P1433 Q4970200 @default.
- Q37718297 P1476 "Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002." @default.
- Q37718297 P2093 "Alliance for Clinical Trials In Oncology (ACTION)" @default.
- Q37718297 P2093 "Bayard L Powell" @default.
- Q37718297 P2093 "Eva Hoke" @default.
- Q37718297 P2093 "Jeffrey L Johnson" @default.
- Q37718297 P2093 "Thomas C Shea" @default.
- Q37718297 P2860 Q28251216 @default.
- Q37718297 P2860 Q33388853 @default.
- Q37718297 P2860 Q33393071 @default.
- Q37718297 P2860 Q33411059 @default.
- Q37718297 P2860 Q33495648 @default.
- Q37718297 P2860 Q34026194 @default.
- Q37718297 P2860 Q34029869 @default.
- Q37718297 P2860 Q34522797 @default.